Artelo Biosciences Inc.

NASDAQ: ARTL · Real-Time Price · USD
10.06
-0.03 (-0.30%)
At close: Aug 15, 2025, 3:49 PM
10.25
1.89%
After-hours: Aug 15, 2025, 07:49 PM EDT

Artelo Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Aug 31, 2021
Net Income
-9.83M -9.29M -10.08M -7.44M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
818K 1.02M 2.46M 1.53M
Other Working Capital
457K 430K -195K -239K
Other Non-Cash Items
-279K -641K -211K 7K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
937K 703K -172K -242K
Operating Cash Flow
-8.35M -8.21M -8.01M -6.14M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-481K -13.69M -13.22M -3.44M
Sales Maturities Of Investments
8.25M 17.19M 16.18M n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
7.77M 3.51M 2.96M -3.44M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 6.01M
Financial Cash Flow
112K 567K n/a 14.11M
Net Cash Flow
-477K -4.07M -5.27M 4.49M
Free Cash Flow
-8.35M -8.21M -8.01M -6.14M